U.S. panel strongly recommends shingles vaccine

NEW YORK (Reuters) - An influential federal health advisory committee on Wednesday recommended that Americans aged 60 and older receive Merck & Co's recently launched Zostavax vaccine to prevent shingles, a painful condition involving blisters caused by the re-activated chicken pox virus.

Continue to U.S. panel strongly recommends shingles vaccine on Reuters: Health.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz